Pharmaceutical Co Ltd Takeda serves as Executive at Cortexyme, Inc., where they oversee executive responsibilities. Since joining the company, Pharmaceutical Co Ltd Takeda has executed 65 insider transactions totaling $210.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 12, 2021 involved selling 10,871 shares valued at $384.7K.
Pharmaceutical Co Ltd Takeda currently holds 3,755,583 shares of Cortexyme, Inc. (CRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharmaceutical Co Ltd Takeda has been a net seller of CRTX stock. They have purchased $5.0M and sold $205.9M worth of shares.
Pharmaceutical Co Ltd Takeda's most recent insider trade was on May 12, 2021, when they sold 10,871 shares at $35.39 per share.
Get notified when new Form 4 filings are submitted
| $35.03 |
| Discretionary |
| May 6, 2021 | PHAT | $7.1K | Sale | 202 | $35.01 | Discretionary |
| May 5, 2021 | PHAT | $243.7K | Sale | 6,936 | $35.14 | Discretionary |
| May 4, 2021 | PHAT | $393.0K | Sale | 11,070 | $35.50 | Discretionary |
| May 4, 2021 | PHAT | $169.8K | Sale | 4,690 | $36.21 | Discretionary |
| May 4, 2021 | PHAT | $131.1K | Sale | 3,500 | $37.47 | Discretionary |
| May 4, 2021 | PHAT | $3.9K | Sale | 100 | $38.53 | Discretionary |
| May 3, 2021 | PHAT | $7.9K | Sale | 203 | $39.06 | Discretionary |
| May 3, 2021 | PHAT | $433.4K | Sale | 11,272 | $38.45 | Discretionary |
| May 3, 2021 | PHAT | $118.7K | Sale | 3,157 | $37.60 | Discretionary |
| Jun 30, 2020 | TBIO | $141.1M | Sale | 6,824,992 | $20.68 | Discretionary |
| Jun 3, 2020 | TBIO | $791.7K | Sale | 40,086 | $19.75 | Discretionary |
| Oct 8, 2019 | OVID | $5.0M | Purchase | 2,000,000 | $2.50 | Discretionary |
| May 13, 2019 | CRTX | $0 | Conversion | 2,679,802 | $N/A | Discretionary |